Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for Long Island Jewish Medical Center located at 270-05 76 Ave, New Hyde Park, NY, 11040 & includes data from NPIs 1285641514, 1174530349, 1982611190
Dexur analyzed Q4 2017 (October to December 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for Long Island Jewish Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 3,200 | 2,981 | ||||||||||
Surgical | 710 | 685 | ||||||||||
Non Surgical | 2,490 | 2,296 | ||||||||||
Cardiovascular | 687 | 622 | ||||||||||
General Medicine | 547 | 501 | ||||||||||
Urology | 296 | 285 | ||||||||||
Gastroenterology & Endocrinology | 287 | 279 | ||||||||||
General Surgery | 261 | 245 | ||||||||||
Orthopedics | 255 | 242 | ||||||||||
Pulmonology | 247 | 229 | ||||||||||
Psychiatry & Mental Disorders | 202 | 188 | ||||||||||
Neurology | 196 | 177 | ||||||||||
Oncology & Hematology | 104 | 97 | ||||||||||
Obstetrics & Gynecology | 36 | 36 | ||||||||||
Colorectal | 33 | 31 | ||||||||||
Spine | 20 | 20 | ||||||||||
Dermatology | 19 | 19 |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Chest Pain | ||||||||||||
DRG 313: CHEST PAIN | ||||||||||||
Acute Myocardial Infarction | ||||||||||||
DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 299: PERIPHERAL VASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Vascular Procedures | ||||||||||||
DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hypertension | ||||||||||||
DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||
Percutaneous Intracardiac Procedures |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Signs And Symptoms | ||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Disequilibrium | ||||||||||||
DRG 149: DYSEQUILIBRIUM | ||||||||||||
Complications Of Treatment |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Renal Failure | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Kidney And Ureter Procedures | ||||||||||||
DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Major Male Pelvic Procedures | ||||||||||||
Urinary Stones | ||||||||||||
DRG 694: URINARY STONES WITHOUT ESW LITHOTRIPSY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 379: G.I. HEMORRHAGE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Diabetes | ||||||||||||
DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
G.I. Obstruction | ||||||||||||
DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
Cholecystectomy | ||||||||||||
Disorders Of Pancreas Except Malignancy |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Chest Procedures | ||||||||||||
DRG 165: MAJOR CHEST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Hernia Procedures | ||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
Skin Debridement |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Medical Back Problems | ||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy | ||||||||||||
Fracture, Sprain, Strain And Dislocation Except Femur, Hip, Pelvis And Thigh | ||||||||||||
DRG 563: FRACTURE SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Signs And Symptoms Of Musculoskeletal System And Connective Tissue | ||||||||||||
DRG 556: SIGNS AND SYMPTOMS OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
Bone Diseases And Arthropathies | ||||||||||||
DRG 554: BONE DISEASES AND ARTHROPATHIES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Fractures Of Hip And Pelvis | ||||||||||||
DRG 536: FRACTURES OF HIP AND PELVIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Bronchitis And Asthma | ||||||||||||
DRG 202: BRONCHITIS AND ASTHMA WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 203: BRONCHITIS AND ASTHMA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Pulmonary Embolism | ||||||||||||
Respiratory Infections And Inflammations | ||||||||||||
Respiratory System Diagnosis With Ventilator Support |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES | ||||||||||||
Organic Disturbances And Intellectual Disability | ||||||||||||
DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | ||||||||||||
Alcohol/Drug Abuse Or Dependence | ||||||||||||
Depressive Neuroses | ||||||||||||
DRG 881: DEPRESSIVE NEUROSES |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
Degenerative Nervous System Disorders | ||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Seizures | ||||||||||||
DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Transient Ischemia | ||||||||||||
DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
Cranial And Peripheral Nerve Disorders |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Red Blood Cell Disorders | ||||||||||||
DRG 812: RED BLOOD CELL DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory Neoplasms | ||||||||||||
Digestive Malignancy |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Uterine And Adnexal Procedures For Malignancy | ||||||||||||
Uterine And Adnexal Procedures For Non-Malignancy |
Total Hospitalizations (Oct 2017 to Dec 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Oct 2017 to Dec 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Oct 2017 to Dec 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||
DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |